What is WellSpring Oncology?
WellSpring Oncology operates as a premier radiation therapy center based in Pinellas Park, Florida, distinguishing itself through a synthesis of high-acuity medical technology and patient-centric design. By integrating advanced systems such as the Varian VitalBeam linear accelerator and HDR brachytherapy, the facility provides sophisticated oncological interventions within a therapeutic, spa-like environment. Beyond traditional cancer treatment, the center demonstrates clinical versatility by offering low-dose radiation therapy for arthritis, thereby diversifying its service portfolio and broadening its patient demographic. The company maintains a strong commitment to accessibility, accepting all major health insurance providers in the region, which solidifies its role as a critical node in the local healthcare ecosystem.
How much funding has WellSpring Oncology raised?
WellSpring Oncology has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in WellSpring Oncology
PPP
Public-Private Partnership
What's next for WellSpring Oncology?
The infusion of capital is expected to catalyze the next phase of the company's growth, likely focusing on the modernization of its existing treatment suites and the potential acquisition of next-generation diagnostic tools. As the organization transitions through this late-stage funding cycle, the strategic priority will shift toward optimizing operational efficiencies and scaling its specialized care model to meet the rising demand for advanced radiation oncology. By leveraging its current technological foundation, WellSpring Oncology is poised to strengthen its market share and continue its trajectory as a leader in compassionate, high-tech cancer care.
See full WellSpring Oncology company page
